{"id":669982,"date":"2023-09-27T18:16:01","date_gmt":"2023-09-27T18:16:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=669982"},"modified":"2023-09-27T18:16:01","modified_gmt":"2023-09-27T18:16:01","slug":"chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-fibrogen-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-fibrogen-and-others_669982.html","title":{"rendered":"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies &#8211; FibroGen, and others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1695793790.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - FibroGen, and others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1695793790.jpeg\" alt=\"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - FibroGen, and others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Chemotherapy-Induced Anemia Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Chemotherapy-Induced Anemia in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight has launched a new report on&nbsp;&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chemotherapy Induced Anemia &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/a>&rdquo;.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Chemotherapy Induced Anemia Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to Langa et al (2015) the prevalence of anemia (hemoglobin [Hb] level<\/li>\n<li>According to study by Cannavale et al (2019),&nbsp; of 699 chemotherapy-treated patients with NHL diagnosed between 2010 and 2012, 36.9% and 11.6% developed moderate (hemoglobin &lt; 10 g\/dL) and severe (hemoglobin &lt; 8 g\/dL) CIA during chemotherapy.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Chemotherapy Induced Anemia market report covers a descriptive overview and comprehensive insight of the Chemotherapy Induced Anemia Epidemiology and Chemotherapy Induced Anemia&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Chemotherapy Induced Anemia market report provides insights on the current and emerging therapies.<\/li>\n<li>Chemotherapy Induced Anemia market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Chemotherapy Induced Anemia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chemotherapy Induced Anemia market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Got queries?&nbsp;Click here to know more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chemotherapy Induced Anemia Market Landscape<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chemotherapy Induced Anemia Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Anemia is the most common and persistent hematological abnormality in oncology patients. Chemotherapy-induced anemia (CIA) is a consequence of the malignant invasion of normal tissue leading to blood loss, bone marrow infiltration with disruption of erythropoiesis, and functional iron deficiency as a consequence of inflammation.<\/p>\n<p style=\"text-align: justify;\">Fatigue is the most common symptom of CIA, although vertigo, loss of appetite, poor concentration, and dyspnea are also frequently reported. Grade of anemia in combination with a type of cancer and baseline cardiopulmonary function contribute to symptom severity.<\/p>\n<p style=\"text-align: justify;\"><strong>Chemotherapy Induced Anemia Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the&nbsp;Chemotherapy Induced Anemia market&nbsp;are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as FibroGen, and others during the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><strong>Learn more by requesting for sample&nbsp;@ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chemotherapy-induced-anemia-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chemotherapy Induced Anemia Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Chemotherapy Induced Anemia Pipeline Therapies and Key Companies<\/a>&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Roxadustat: FibroGen<\/li>\n<li>And Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Chemotherapy Induced Anemia Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Chemotherapy Induced Anemia Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Chemotherapy Induced Anemia Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Chemotherapy Induced Anemia Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Chemotherapy-Induced Anemia&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Chemotherapy Induced Anemia Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Chemotherapy Induced Anemia Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Chemotherapy Induced Anemia Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Chemotherapy Induced Anemia Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Chemotherapy Induced Anemia Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Request for a detailed sample report @&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chemotherapy-induced-anemia-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/chemotherapy-induced-anemia-market<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-fibrogen-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91-9650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-fibrogen-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chemotherapy-Induced Anemia Market DelveInsight\u2019s \u2018Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Chemotherapy-Induced Anemia in the United States, EU5 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-fibrogen-and-others_669982.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-669982","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/669982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=669982"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/669982\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=669982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=669982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=669982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}